ACB + IPACK Block With or Without Local Infiltration in RA-TKA
NCT ID: NCT03840122
Last Updated: 2019-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2019-10-08
2019-10-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Levels and Opioid Usage in Three Nerve Block Cohorts in Primary TKA
NCT04292392
Comparing Two Regional Anesthesia Interventions for Knee Arthroplasty.
NCT03944005
Comparison of IPACK Block and PCI for Postoperative Analgesia and Function Recovery Following Total Knee Arthroplasty
NCT05943080
Effect of Continuous Adductor Canal Block Versus Continuous Adductor Canal Block With Additional Infiltration Between The Popliteal Artery and Capsule of The Knee (IPACK) After Arthroscopic Knee Surgeries
NCT06802419
The Analgesic Efficacy of Protocol for Primary Total Knee Arthroplasty (TKA)
NCT03703206
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A - ACB + IPACK with injection
50 arms: ACB + IPACK block with injection of local anesthetic of Ropivacaine, Epinephrine, Ketorolac, Clonidine and saline
ACB + IPACK block with injection of local anesthetic
ACB + IPACK block with injection of local anesthetic which is comprised of the following agents and amounts:
* Ropivacaine 5mg/ml (49.25ml)
* Epinephrine 1mg/ml (0.5ml)
* Ketorolac 30mg/ml (1ml)
* Clonidine 0.1mg/ml (0.8ml)
* Saline 48.45ml
B - ACB + IPACK without injection
50 arms: ACB + IPACK block without injection of local anesthetic
ACB + IPACK block without injection
ACB + IPACK block without an injection of local anesthetic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACB + IPACK block with injection of local anesthetic
ACB + IPACK block with injection of local anesthetic which is comprised of the following agents and amounts:
* Ropivacaine 5mg/ml (49.25ml)
* Epinephrine 1mg/ml (0.5ml)
* Ketorolac 30mg/ml (1ml)
* Clonidine 0.1mg/ml (0.8ml)
* Saline 48.45ml
ACB + IPACK block without injection
ACB + IPACK block without an injection of local anesthetic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient is scheduled to undergo a unilateral, primary TKA, secondary to osteoarthritis
3. Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization documents
4. Patient is able to read and speak English.
Exclusion Criteria
2. Patient's primary diagnosis is not osteoarthritis (e.g. post-traumatic arthritis)
3. Patient is scheduled to undergo a bilateral TKA surgery
4. Patient is unable to read and speak English
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Louisville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arthur Malkani
Professor, Adult Reconstruction
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arthur Malkani, MD
Role: PRINCIPAL_INVESTIGATOR
University of Louisville
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jewish Hospital
Louisville, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18.1246
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.